Patients with active cancer and newly diagnosed isolated distal deep vein thrombosis (DVT) who received 12 months of edoxaban (Savaysa) had fewer thrombotic events at 1 […]

Previously reported associations between fluoroquinolone use and risk for hospitalization with aortic aneurysm or dissection may be due to confounding, an observational study using two databases […]

TOPLINE: There are no significant differences in 1-year mortality, survival to hospital discharge, severe primary graft dysfunction (PGD), and other outcomes post heart transplant between patients […]

The American Heart Association (AHA) has released a focused update on managing patients with cardiac arrest or life-threatening toxicity due to poisoning. The update reflects treatment […]

TOPLINE: A new study finds SARS-CoV-2 directly infects the coronary vasculature and causes plaque inflammation, which could help explain why people with COVID-19 have an increased […]

Moving from one residence to another after an acute myocardial infarction (AMI) significantly increases the risk for death or transition to a long-term care facility as […]

TOPLINE: Contrary to what the authors had hypothesized, stroke and hypertension are not important mediators of the association between fine particulate matter (PM2.5) and dementia, findings […]

The quest to find an anticoagulant that can prevent strokes, cardiovascular events, and venous thrombosis without significantly increasing risk of bleeding is something of a holy […]

TOPLINE: The investigational intranasal L-type calcium channel blocker etripamil continues to be well tolerated and effective for self-treating recurrent episodes of paroxysmal supraventricular tachycardia (PSVT), results […]